1st EMA MedDRA Information Day

Session 1 will provide a brief overview of the evolution of MedDRA to meet the needs of users. This includes a discussion of several initiatives including medication error terms, device terms, product quality issue terms, vaccine terms, microorganism terms, terms related to chemical health threats, pharmacogenetic terms, and neoplasm terms. A brief discussion of the process to add these various types of terms within the scope of MedDRA will also be discussed.